HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Enhanced expression of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-6 in bronchoalveolar lavage cells from patients with sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001
Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Upregulation of neurokinin-1 receptor expression in bronchoalveolar lavage cells and bronchial epithelium of patients with sarcoidosis compared with normal patients Source: Eur Respir J 2002; 20: Suppl. 38, 226s Year: 2002
Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Upregulation of expression of membrane apoptosis signals by bronchoalveolar lavage cells in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Impaired expression of telomerase activity in bronchoalveolar lavage fluid cells in patients with lung cancer: Preliminary results Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003
Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in serum and bronchoalveolar lavage fluid of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004
An indicative role of serum transforming growth factor-beta 1 (TGF-β1) level on the determination of clinical severity of pulmonary tuberculosis Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005
Increased expression of tumor necrosis factor receptors by bronchoalveolar cells in cryptogenic organising pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 565s Year: 2006
Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location Source: International Congress 2017 – ILDs: clinical problems Year: 2017
Activation of discoidin domain receptor 1 on CD14 positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006
Toll-like receptor 4 is overexpressed in bronchoalveolar lavage fluid of patients with fibrotic idiopathic interstitial pneumonias (F-IIPs): preliminary results Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009
Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Comparative analysis of surface antigen expression and DNA content in circulating, tissue and bronchoalveolar lavage lymphocytes in patients with COPD after radiation exposure Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002